Collins EJ - Search Results

1

Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.

Vincent BG, File DM, McKinnon KP, Moore DT, Frelinger JA, Collins EJ, Ibrahim JG, Bixby L, Reisdorf S, Laurie SJ, Park YA, Anders CK, Collichio FA, Muss HB, Carey LA, van Deventer HW, Dees EC, Serody JS. Vincent BG, et al. Among authors: collins ej. J Immunol. 2023 Jul 15;211(2):219-228. doi: 10.4049/jimmunol.2300077. J Immunol. 2023. PMID: 37204246 Free PMC article. Clinical Trial.

2

T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery.

Serody JS, Collins EJ, Tisch RM, Kuhns JJ, Frelinger JA. Serody JS, et al. Among authors: collins ej. J Immunol. 2000 May 1;164(9):4961-7. doi: 10.4049/jimmunol.164.9.4961. J Immunol. 2000. PMID: 10779807

3

Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.

Reed AM, Collins EJ, Shock LP, Klapper DG, Frelinger JA. Reed AM, et al. Among authors: collins ej. J Immunol. 1997 Dec 15;159(12):6260-5. J Immunol. 1997. PMID: 9550430

4

Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells.

Wang B, Maile R, Greenwood R, Collins EJ, Frelinger JA. Wang B, et al. Among authors: collins ej. J Immunol. 2000 Feb 1;164(3):1216-22. doi: 10.4049/jimmunol.164.3.1216. J Immunol. 2000. PMID: 10640733

5

Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers.

Maile R, Wang B, Schooler W, Meyer A, Collins EJ, Frelinger JA. Maile R, et al. Among authors: collins ej. J Immunol. 2001 Oct 1;167(7):3708-14. doi: 10.4049/jimmunol.167.7.3708. J Immunol. 2001. PMID: 11564786

6

Peptidic termini play a significant role in TCR recognition.

Wang B, Sharma A, Maile R, Saad M, Collins EJ, Frelinger JA. Wang B, et al. Among authors: collins ej. J Immunol. 2002 Sep 15;169(6):3137-45. doi: 10.4049/jimmunol.169.6.3137. J Immunol. 2002. PMID: 12218131

7

High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC.

Buslepp J, Kerry SE, Loftus D, Frelinger JA, Appella E, Collins EJ. Buslepp J, et al. Among authors: collins ej. J Immunol. 2003 Jan 1;170(1):373-83. doi: 10.4049/jimmunol.170.1.373. J Immunol. 2003. PMID: 12496422

8

Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer.

Dees EC, McKinnon KP, Kuhns JJ, Chwastiak KA, Sparks S, Myers M, Collins EJ, Frelinger JA, Van Deventer H, Collichio F, Carey LA, Brecher ME, Graham M, Earp HS, Serody JS. Dees EC, et al. Among authors: collins ej. Cancer Immunol Immunother. 2004 Sep;53(9):777-85. doi: 10.1007/s00262-004-0520-1. Epub 2004 Jun 8. Cancer Immunol Immunother. 2004. PMID: 15185007 Free PMC article.

9

Memory CD8 T cells require CD8 coreceptor engagement for calcium mobilization and proliferation, but not cytokine production.

Kerry SE, Maile R, Collins EJ, Frelinger JA. Kerry SE, et al. Among authors: collins ej. Immunology. 2005 Jan;114(1):44-52. doi: 10.1111/j.1365-2567.2004.02070.x. Immunology. 2005. PMID: 15606794 Free PMC article.

10

Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo.

Maile R, Siler CA, Kerry SE, Midkiff KE, Collins EJ, Frelinger JA. Maile R, et al. Among authors: collins ej. J Immunol. 2005 Jan 15;174(2):619-27. doi: 10.4049/jimmunol.174.2.619. J Immunol. 2005. PMID: 15634879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters